GDF15 and obesity due to melanocortin 4 receptor deficiency: GDF-15 shows great promise to be a biomarker for disease prediction and prognosis, identifying at-risk groups who may benefit from intensive intervention and the potential application of GDF-15-based therapies in cancer cachexia, DM, and obesity.